Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001140361-25-004927
Filing Date
2025-02-18
Accepted
2025-02-18 06:30:16
Documents
6

Document Format Files

Seq Description Document Type Size
1 424B5 ny20043420x2_424b5.htm 424B5 750268
2 logo_inflarx.jpg GRAPHIC 24927
3 logo_inflarxx1.jpg GRAPHIC 27642
4 logo_inflarxx2.jpg GRAPHIC 29996
5 ny20043420x2_barchart01.jpg GRAPHIC 324660
6 ny20043420x2_barchart02.jpg GRAPHIC 220285
  Complete submission text file 0001140361-25-004927.txt   1614679
Mailing Address WINZERLAER STR. 2 JENA 2M 07745
Business Address WINZERLAER STR. 2 JENA 2M 07745 49 3641 508180
InflaRx N.V. (Filer) CIK: 0001708688 (see all company filings)

EIN.: 000000000 | State of Incorp.: P7 | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-273058 | Film No.: 25632627
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)